Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Mazdutide

A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight

Innovent · Phase 2 · Completed · Enrollment 179

NCT06124807

ArmPopulationDoseWeeksEstimandWeight change
3/6 Milligrams (mg) MazdutideObesity or overweightn/rn/rn/rn/r
10 mg MazdutideObesity or overweight10 mg32n/r96.1% at week 32
16 mg MazdutideObesity or overweight16 mg32n/r92.23% at week 32
PlaceboObesity or overweightn/r32n/r23.97% at week 32
3/6 mg MazdutideObesity or overweight6 mg32n/r67.64% at week 32